Skip to Main Content

Amid concerns over access to medicines that were hatched with U.S. taxpayer funds, Democratic lawmakers have asked the Government Accountability Office to investigate the discovery and development of remdesivir, which is the first drug authorized to treat Covid-19.

In a letter to the congressional watchdog, the lawmakers argue that the medicine, which is sold by Gilead Sciences (GILD), eventually reached patients thanks, in part, to an estimated $70 million in federal funding and ”key scientific contributions” from U.S. government scientists.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!